# Aureva Transcranial Ultrasound Device With tPA in Patients With Acute Ischemic Stroke

Study · id `cardio:ct-nct03519737` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT03519737](<https://clinicaltrials.gov/study/NCT03519737>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT03519737

Browse, organ or system: Brain  
Browse, condition area: Stroke  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 596 participants.

## Technical summary

Registry record NCT03519737. Randomized; quadruple masking; primary purpose treatment. Start 2018-08-17 (actual); primary completion 2021-11-30 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 596 participants (planned count; ClinicalTrials.gov record NCT03519737, source copy `cardio:ctgov-nct03519737-2018-11-30`, retrieved 2026-10-26)
- Started: 2018-08-17 (actual) (ClinicalTrials.gov record NCT03519737, source copy `cardio:ctgov-nct03519737-2018-11-30`, retrieved 2026-10-26)
- Primary completion: 2021-11-30 (anticipated) (ClinicalTrials.gov record NCT03519737, source copy `cardio:ctgov-nct03519737-2018-11-30`, retrieved 2026-10-26)
- Completion: 2021-12-31 (anticipated) (ClinicalTrials.gov record NCT03519737, source copy `cardio:ctgov-nct03519737-2018-11-30`, retrieved 2026-10-26)
- Countries: United States (ClinicalTrials.gov record NCT03519737, source copy `cardio:ctgov-nct03519737-2018-11-30`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct03519737-2018-11-30`, retrieved 2026-10-26)

## The registry's words

- Brief title: Aureva Transcranial Ultrasound Device With tPA in Patients With Acute Ischemic Stroke
- Acronym: TRUST
- Condition: Acute Ischemic Stroke
- Intervention (Device): tPA in combination with the Sonolysis Headframe (TUS)
- Intervention (Device): tPA in combination with the Sonolysis Headframe (Sham TUS)
- Lead sponsor: Cerevast Medical, Inc.
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Ischemic stroke (`cardio:ischemic-stroke`)
- Registry condition terms include this condition: Stroke (`core:stroke`)

## Provenance

Content hash: 70b7e5adb103edfb2b53f975cbdd2518ae1e3560302f1bd1f19ce80b18572a5b
Last substantive edit: 2026-10-31
Evidence last checked: Not recorded
